Dietary advanced glycation end products and their role in health and disease
Week 13 16: Initiate at 1.7 mg once weekly for 4 weeks
The approval, a third indication for Blincyto, was supported by the Phase III E1910 clinical trial, in which Amgens drug plus multiphase consolidation chemotherapy showed superior overall survival versus chemotherapy alone
However, the pilot, largely funded by the federal government, is set to expire after 2027, and health insurers have balked at a longer-term program that would shift costs onto them
Studies comparing medicationonly care to programs that combine GLP1 therapy with nutrition and behavioural support show better sustained weight loss, fewer side effects and less weight regain once the drug is stopped in the supported groups (Wilding et al., 2021)